{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:55:50Z","timestamp":1790420150456,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00152","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T05:16:38Z","timestamp":1584422198000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["The Broad Concept of \u201cSpasticity-Plus Syndrome\u201d in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms"],"prefix":"10.3389","volume":"11","author":[{"given":"\u00d3scar","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienne","family":"Costa-Frossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Mart\u00ednez-Gin\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Maria","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Rami\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nrneurol.2015.14","article-title":"Multiple sclerosis-a quiet revolution","volume":"11","author":"Ransohoff","year":"2015","journal-title":"Nat Rev Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/jnnp-2016-315238","article-title":"Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study","volume":"88","author":"Lunde","year":"2017","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/ane.12202","article-title":"Spasticity in patients with multiple sclerosis\u2013clinical characteristics, treatment and quality of life","volume":"129","author":"Flachenecker","year":"2014","journal-title":"Acta Neurol Scand."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1177\/1352458512458169","article-title":"Setting a research agenda for progressive multiple sclerosis: the international collaborative on progressive MS","volume":"18","author":"Fox","year":"2012","journal-title":"Mult Scler."},{"key":"B5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/msj.20245","article-title":"Therapeutics for multiple sclerosis symptoms","volume":"78","author":"Ben-Zacharia","year":"2011","journal-title":"Mt Sinai J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1474-4422(10)70249-0","article-title":"Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions","volume":"9","author":"Thompson","year":"2010","journal-title":"Lancet Neurol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/B978-0-444-52001-2.00023-6","article-title":"Symptomatic treatment and management of multiple sclerosis","volume-title":"Handbook of Clinical Neurology Multiple Sclerosis Related Disorders","author":"Toosy","year":"2014"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2217\/nmt-2018-0050","article-title":"Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from randomized clinical trials","volume":"9","author":"Markov\u00e1","year":"2019","journal-title":"Neurodegener Dis Manag."},{"key":"B9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.7224\/1537-2073.2012-053","article-title":"Natural history of multiple sclerosis symptoms","volume":"15","author":"Kister","year":"2013","journal-title":"Int J MS Care"},{"key":"B10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s00415-009-5403-0","article-title":"Clinical features of CIS of the brainstem\/cerebellum of the kind seen in MS","volume":"257","author":"Sastre-Garriga","year":"2010","journal-title":"J Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jns.2016.10.040","article-title":"Sleep and fatigue in multiple sclerosis: a questionnaire-based, cross-sectional, cohort study","volume":"372","author":"Nociti","year":"2017","journal-title":"J Neurol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"10","author":"Rizzo","year":"2004","journal-title":"Mult Scler Houndmills Basingstoke Engl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.msard.2015.10.007","article-title":"spasticity in multiple sclerosis: associations with impairments and overall quality of life","volume":"5","author":"Milinis","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/0888439002250449","article-title":"Spasticity in multiple sclerosis","volume":"17","author":"Barnes","year":"2003","journal-title":"Neurorehabil Neural Repair."},{"key":"B15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/NPT.0b013e31822a8c40","article-title":"Influence of spasticity on mobility and balance in persons with multiple sclerosis","volume":"35","author":"Sosnoff","year":"2011","journal-title":"J Neurol Phys Ther JNPT."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s12325-009-0082-x","article-title":"Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis","volume":"26","author":"Zwibel","year":"2009","journal-title":"Adv Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/1352458508088916","article-title":"Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable","volume":"14","author":"Heesen","year":"2008","journal-title":"Mult Scler Houndmills Basingstoke Engl."},{"key":"B18","unstructured":"HellerM\n            TaylorD\n          Greater Expectations: The Future Hopes of People With Multiple Sclerosis2017"},{"key":"B19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/00207454.2012.762364","article-title":"Spasticity in multiple sclerosis: results of a patient survey","volume":"123","author":"Oreja-Guevara","year":"2013","journal-title":"Int J Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"CD005029","DOI":"10.1002\/14651858.CD005029.pub2","article-title":"Treatment for ataxia in multiple sclerosis","volume":"24","author":"Mills","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/brain\/124.4.720","article-title":"A study of tremor in multiple sclerosis","volume":"124","author":"Alusi","year":"2001","journal-title":"Brain J Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2165\/00003495-200363020-00003","article-title":"Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies","volume":"63","author":"DasGupta","year":"2003","journal-title":"Drugs."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1177\/1352458508093619","article-title":"The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis","volume":"14","author":"Tepavcevic","year":"2008","journal-title":"Mult Scler Houndmills Basingstoke Engl."},{"key":"B24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/135245850100700404","article-title":"Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction","volume":"7","author":"Nortvedt","year":"2001","journal-title":"Mult Scler Houndmills Basingstoke Engl."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/0016-5085(90)91087-M","article-title":"Prevalence of bowel dysfunction in multiple sclerosis. a population survey","volume":"98","author":"Hinds","year":"1990","journal-title":"Gastroenterology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1191\/1352458503ms904oa","article-title":"Fatigue associated with multiple sclerosis: diagnosis, impact and management","volume":"9","author":"Bakshi","year":"2003","journal-title":"Mult Scler."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1191\/1352458505ms1168oa","article-title":"Severity of chronic pain and its relationship to quality of life in multiple sclerosis","volume":"11","author":"Kalia","year":"2005","journal-title":"Mult Scler."},{"key":"B29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s00415-009-5441-7","article-title":"Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management","volume":"257","author":"Simmons","year":"2010","journal-title":"J Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"CD012732","DOI":"10.1002\/14651858.CD012732.pub2","article-title":"Rehabilitation for people with multiple sclerosis: an overview of cochrane reviews","volume":"1","author":"Amatya","year":"2019","journal-title":"Cochr Database of Syst Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.7224\/1537-2073.2016-062","article-title":"A framework of care in multiple sclerosis, part 2: symptomatic care and beyond","volume":"19","author":"Newsome","year":"2017","journal-title":"Int J MS Care."},{"key":"B32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.33588\/rn.5708.2013374","article-title":"Consensus document on spasticity in patients with multiple sclerosis. grupo de enfermedades desmielinizantes de la sociedad espa\u00f1ola de neurolog\u00eda","volume":"57","author":"Oreja-Guevara","year":"2013","journal-title":"Rev Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ncpuro1298","article-title":"Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management","volume":"6","author":"Fletcher","year":"2009","journal-title":"Nat Clin Pract Urol"},{"key":"B34","first-page":"177","volume-title":"Illustrated Medical Dictionary","year":"2002"},{"key":"B35","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.autrev.2017.07.004","article-title":"Spasticity in multiple sclerosis: contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions","volume":"16","author":"Patejdl","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/jnnp.56.3.245","article-title":"Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis","volume":"56","author":"Betts","year":"1993","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.autrev.2015.11.005","article-title":"Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration","volume":"15","author":"Patejdl","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jpainsymman.2009.11.312","article-title":"Symptom cluster and quality of life in multiple sclerosis","volume":"39","author":"Motl","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"B39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures\u2013a short review","volume":"90","author":"Sv\u00edzensk\u00e1","year":"2008","journal-title":"Pharmacol Biochem Behav."},{"key":"B40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","article-title":"The cannabinoid receptors","author":"Howlett","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"van Sickle","year":"2005","journal-title":"Science."},{"key":"B42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.bjp.0707458","article-title":"Cannabinoid control of neuroinflammation related to multiple sclerosis","volume":"152","author":"Baker","year":"2007","journal-title":"Br J Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms inmultiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult Scler."},{"key":"B44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1468-1331.2006.01639.x","article-title":"Sativex spasticity in MS study group. randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis","volume":"14","author":"Collin","year":"2007","journal-title":"Eur J Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1179\/016164109X12590518685660","article-title":"A double-blind, randomized, placebo-controlled, parallel-group study of sativex, in subjects with symptoms of spasticity due to multiple sclerosis","volume":"32","author":"Collin","year":"2010","journal-title":"Neurol Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(\u00ae)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis","volume":"18","author":"Novotna","year":"2011","journal-title":"Eur J Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00207454.2018.1481066","article-title":"Sativex\u00ae as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial","volume":"129","author":"Markov\u00e0","year":"2019","journal-title":"Int J Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000367618","article-title":"Advances in the management of MS spasticity: recent observational studies","volume":"72","author":"Fern\u00e1ndez","year":"2014","journal-title":"Eur Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00192-006-0086-x","article-title":"The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)","volume":"17","author":"Freeman","year":"2006","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/1352458510378020","article-title":"Randomized controlled trial of sativex to treat detrusor overactivity in multiple sclerosis","volume":"16","author":"Kavia","year":"2010","journal-title":"Mult Scler."},{"key":"B52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1185\/030079906X158066","article-title":"Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain","volume":"23","author":"Iskedjian","year":"2007","journal-title":"Curr Med Res Opin."},{"key":"B53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2217\/cer.14.30","article-title":"Impact of Sativex(\u00ae) on quality of life and activities of daily living in patients with multiple sclerosis spasticity","volume":"3","author":"Arroyo","year":"2014","journal-title":"J Comp Eff Res."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00152\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T05:16:41Z","timestamp":1584422201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00152\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":53,"alternative-id":["10.3389\/fneur.2020.00152"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00152","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"article-number":"152"}}